Clinical Trials Browser

Phase 2 × Thyroid Diseases × Everolimus × Clear all

NCT01141309 2025-07-22

Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer

Phase 2 Active not recruiting

Thyroid Diseases, Thyroid Neoplasms